CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses
By Guo-Yun Chen, Jie Tang, P. Zheng, Yang Liu. Science, 2009
774 citations recorded by the source corpus.
Subfields: Clinical Biochemistry, Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/fc7f04c13e1e65ff51a2011a1a218c0ed18246f8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Clinical Biochemistry
In Immunology
In Molecular Biology
Citations in the corpus
- HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection (2011, positive): “by immunocytes, which in turn associates with Siglec-10 to selectively suppress the nuclear translocation of NF-κB induced by HMGB1-mediated TLR4 activation, but not pathogen-mediated TLR activation (29).”
- Tumour-initiating cells: challenges and opportunities for anticancer drug discovery (2009, background): “Certain markers used for prospective sorting may also select for cells that evade the immune syste”
- PAMPs and DAMPs: Signal 0s that Spur Autophagy and Immunity (2012, background): “CD24 serves as a negative signaling molecule to limit DAMP- but not PAMP-mediated inflammation (73).”
- Phagocyte partnership during the onset and resolution of inflammation (2010, background): “Interestingly, it has recently been shown that HMGB1 can interact with CD24 , a glycosylphosphatidylinositol (GPI)-anchored membrane protein, which in turn binds sialic acid-binding immunoglobulin-like lectin G (SIGLECG”
- Immune activation in brain aging and neurodegeneration: too much or too little? (2009, background): “Additional receptors also exist that appear to selectively recognize DAMPs, including CD24 and receptor for advanced glycation end-products (RAGE) (Arancio et al., 2004; Chen et al., 2009).”
- Decoding cell death signals in liver inflammation. (2013, background): “HSPs Molecular chaperons Adjuvants Anti-inflammatory function (?) TLR2 TLR4 Released upon PMP or secreted via active, exosome-dependent routes Implicated in the response to hepatic IR and other hepatotoxic conditions [48, 134-136]”
- DAMPening Inflammation by Modulating TLR Signalling (2010, background): “Dysfunction of this pathway might contribute to the etiology of autoimmune diseases and likewise may offer a means to selectively inhibit DAMP activity [198].”
- Biological roles of glycans (2016, background): “A clear example of glycan-based SAMPs has been reported in the form of inhibitory Siglec recognition of cell surface sialoglycans (962) (963) (964) , which may also provide a mechanism for the host to discriminate between infectious nonself and noninfectious self (965) .”